# 0703-3678-01 · Methotrexate Sodium Injection · Teva Pharmaceuticals USA, Inc. — FDA drug shortage duration tracker

For 0703-3678-01 · Methotrexate Sodium Injection · Teva Pharmaceuticals USA, Inc., package ndc is 0703-3678-01; generic name is Methotrexate Sodium Injection; manufacturer is Teva Pharmaceuticals USA, Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.

- **Package NDC:** 0703-3678-01 _(verified: appears in the quote below)_
- **Generic name:** Methotrexate Sodium Injection _(verified: appears in the quote below)_
- **Manufacturer:** Teva Pharmaceuticals USA, Inc. _(verified: appears in its own passage below)_
- **Status:** Current _(verified: appears in its own passage below)_
- **Availability now:** Unavailable _(verified: appears in the quote below)_
- **FDA note:** Estimated recovery: October 2026 _(verified: appears in the quote below)_
- **Initial posting date:** 03/13/2023 _(verified: appears in the quote below)_
- **Last update date:** 08/17/2026 _(verified: appears in its own passage below)_
- **Days in shortage:** 1268 _(our reading, not quoted from the source)_
- **Reason for shortage:** Other _(verified: appears in its own passage below)_
- **Dosage form:** Injection _(verified: appears in its own passage below)_
- **Therapeutic category:** Rheumatology _(verified: appears in its own passage below)_

## What the source says

> "initial_posting_date": "03/13/2023", "package_ndc": "0703-3678-01", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-545-8800", "availability": "Unavailable", "related_info": "Estimated recovery: October 2026"

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Manufacturer

> "update_date": "08/17/2026", "therapeutic_category": [ "Rheumatology", "Oncology" ], "dosage_form": "Injection", "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

### Status

> "update_date": "08/17/2026", "therapeutic_category": [ "Rheumatology", "Oncology" ], "dosage_form": "Injection", "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

### Last update date

> "update_date": "08/17/2026", "therapeutic_category": [ "Rheumatology", "Oncology" ], "dosage_form": "Injection", "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

### Reason for shortage

> "update_date": "08/17/2026", "therapeutic_category": [ "Rheumatology", "Oncology" ], "dosage_form": "Injection", "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

### Dosage form

> "update_date": "08/17/2026", "therapeutic_category": [ "Rheumatology", "Oncology" ], "dosage_form": "Injection", "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

### Therapeutic category

> "update_date": "08/17/2026", "therapeutic_category": [ "Rheumatology", "Oncology" ], "dosage_form": "Injection", "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"

## The same source also states

> "initial_posting_date": "03/13/2023", "package_ndc": "0703-3678-01", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-545-8800", "availability": "Limited Availability", "related_info": "Estimated recovery: October 2026"

Source: https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000

## Source

- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000

Last verified: 2026-09-01. Review by: 2026-09-04.
Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).